[Case report of a patient with advanced pelvic and ureteral cancer whose primary lesion could be enucleated after cytoreduction by modified CAP regimen].
A 52-year-old man got right renal pelvic and ureteral carcinoma involving metastases in lung, and para-aortic and supraclavicular nodes, he underwent courses of combination chemotherapy consisting of cyclophosphamide, adriamycin and cisplatinum, including bleomycin. The initial response was encouraging with some regression of the primary tumor and pulmonary metastases. Accordingly, the patient then underwent extirpation of the primary cancer. Two weeks after the surgery, relapse of the lung metastatic lesion was observed, and the lesion was refractory to the chemotherapy. This investigation reports a case and discusses the pre-and-postoperative chemotherapy for upper urothelial carcinoma.
Mikata
N
N
Dept. of Urology, Tokyo Metropolitan Bokutoh Hospital.
Imao
S
S
Katoh
A
A
Horiuti
D
D
Tanaka
Y
Y
Sasaki
H
H
Hamasima
T
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D007682:Kidney Pelvis; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D009392:Nephrectomy; D014516:Ureteral Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D001761:Bleomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin